Clinical Trial Update: Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether saxagliptin improves microalbuminuria in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR | Phase 4 | Status: UNKNOWN